Laman UtamaSHTDF • OTCMKTS
add
Sinopharm Group Co Ltd
Tutup sebelumnya
$1.97
Julat tahun
$1.97 - $2.95
Permodalan pasaran
63.04B HKD
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
HKG
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (CNY) | Jun 2024info | Perubahan T/T |
|---|---|---|
Hasil | 147.46B | -5.13% |
Perbelanjaan pengendalian | 6.38B | -2.07% |
Pendapatan bersih | 2.28B | -9.16% |
Margin untung bersih | 1.55 | -4.32% |
Pendapatan bagi setiap syer | — | — |
EBITDA | 5.57B | -12.42% |
Kadar cukai berkesan | 21.74% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (CNY) | Jun 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 43.33B | 26.05% |
Jumlah aset | 429.58B | 2.85% |
Jumlah liabiliti | 307.15B | 0.84% |
Jumlah ekuiti | 122.43B | — |
Syer tertunggak | 3.12B | — |
Harga kepada buku | 0.08 | — |
Pulangan pada aset | 2.96% | — |
Pulangan pada modal | 5.84% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (CNY) | Jun 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 2.28B | -9.16% |
Tunai daripada operasi | 6.49B | 346.39% |
Tunai daripada pelaburan | -1.29B | -269.35% |
Tunai daripada pembiayaan | -602.70J | -425.16% |
Perubahan bersih dalam tunai | 4.59B | 374.61% |
Aliran tunai bebas | -22.56B | 29.73% |
Perihal
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Diasaskan
2003
Tapak web
Pekerja
113,635
